Santhera raises EUR 7 million

Neuromuscular and metabolic disease company Santhera (Basel, Switzerland) raised EUR 7 million ($9.3 million) in the second closing of its first private round, bringing the total raised in the round to EUR 14 million ($18.5 million). The round was led by NGN and included Altana Innovationsfond and Heidelberg Innovation. Georg Nebgen of NGN joined the company's board. ...